| Sydney Therese Pelster, OTR/L | |
|
5954 S Quatar Ct, Aurora, CO 80015-5015 | |
| (303) 250-4291 | |
| (720) 306-2352 |
| Full Name | Sydney Therese Pelster |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 5954 S Quatar Ct, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205470374 | NPI | - | NPPES |
| 74785303 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT.0006216 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sydney Therese Pelster, OTR/L 5954 S Quatar Ct, Aurora, CO 80015-5015 Ph: (303) 250-4291 | Sydney Therese Pelster, OTR/L 5954 S Quatar Ct, Aurora, CO 80015-5015 Ph: (303) 250-4291 |
News Archive
For pancreatic cancer patients unable to undergo surgery the only known cure for this form of cancer a highly targeted cancer radiation therapy may help slow cancer progression and lessen disease symptoms, according to researchers at Henry Ford Hospital in Detroit.
Spinal Modulation, Inc. announced today the completion of its $30 million Series D financing. Medtronic, Inc. joined existing investors DeNovo Ventures, ePlanet/DFJ, InCube Ventures, Johnson & Johnson Development Corporation (JJDC), Kleiner Perkins Caufield & Byers, MedVenture Associates, and Raffles Venture Partners.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced positive top-line results from the IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) Phase III clinical program of XIAFLEX for the treatment of Peyronie's disease, which was conducted by BioSpecifics' partner Auxilium Pharmaceuticals, Inc.
Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.
› Verified 5 days ago
Ms. Carol Yvonne Wall, O.T.R., C.E.A.S Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3451 S Chambers Rd, Aurora, CO 80014 Phone: 303-680-6121 Fax: 303-680-8627 | |
Hatti Owens, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15751 E 1st Ave, Aurora, CO 80011 Phone: 303-340-0510 | |
Mrs. Sanja June Batz, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-7447 | |
Lilly O'toole, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7795 S Blackstone Pkwy, Aurora, CO 80016 Phone: 720-886-1400 | |
Susanna Muth, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 24300 E Progress Dr, Aurora, CO 80016 Phone: 720-886-4000 | |
Alexis Reinert, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5954 S Quatar Ct, Aurora, CO 80015 Phone: 303-250-4291 Fax: 720-306-2352 | |
Alyssa Fasoli, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15701 E 1st Ave Ste 109, Aurora, CO 80011 Phone: 303-367-3060 |